Investing
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer’s disease is now available for consumer purchase....

